Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
21,628
-1,969
-8% -$91.8K ﹤0.01% 1034
2025
Q4
$1.14M Sell
23,597
-4,045
-15% -$201K ﹤0.01% 992
2025
Q3
$1.3M Buy
27,642
+14,810
+115% +$715K ﹤0.01% 914
2025
Q2
$620K Buy
12,832
+869
+7% +$44.4K ﹤0.01% 1063
2025
Q1
$663K Buy
11,963
+2,443
+26% +$132K 0.01% 873
2024
Q4
$459K Buy
9,520
+1,175
+14% +$59.7K ﹤0.01% 877
2024
Q3
$481K Buy
8,345
+1,590
+24% +$85.8K 0.01% 765
2024
Q2
$328K Buy
6,755
+1,480
+28% +$71.4K ﹤0.01% 781
2024
Q1
$256K Buy
5,275
+702
+15% +$34.3K ﹤0.01% 805
2023
Q4
$227K Sell
4,573
-389
-8% -$19K ﹤0.01% 807
2023
Q3
$266K Buy
4,962
+577
+13% +$30.8K 0.01% 759
2023
Q2
$236K Buy
+4,385
New +$236K ﹤0.01% 762

Other funds holding SNY

IEQ Capital's SNY Position: Q1 2026 in Review

IEQ Capital reduced its Sanofi (SNY) stake by 8.3% in Q1 2026, selling an estimated $91.8K and leaving 21,628 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

IEQ Capital first reported a position in SNY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.3M in Q3 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • IEQ Capital held 21,628 shares of Sanofi worth $1.04M as of Q1 2026.
  • IEQ Capital sold 1,969 Sanofi shares in Q1 2026, an estimated $91.8K.
  • Sanofi made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1034 holding.
  • IEQ Capital first reported a position in Sanofi in Q2 2023 and has held it in 12 quarters since.
  • IEQ Capital's Sanofi position peaked at $1.3M in Q3 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.